Research appearing in the Journal of Medicinal Chemistry shows for the first time SARS-CoV-2, the virus responsible for COVID-19, can be inhibited from replicating in living cell cultures using a ...

A schematic diagram showing the significant contribution of SCoV2-induced altered mitochondrial dynamics and mitochondrial EGFR translocation in sustaining viral propagation. First, SCOV2 RNA and ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of science, technology, and medicine news ...

According to an article published in the journal PLOS Pathogens, severe COVID-19 patients can be divided into two distinct groups: those with a high viral load and relatively little inflammation, and ...

New research reveals that even mild respiratory infections can leave lasting biological changes. However, COVID-19 stands ...

The technology, called the Viral-Engineered RNA-based Activation System (VERAS), hijacks the virus’s own replication machinery to switch on reporter or therapeutic genes precisely in infected cells.

Researchers found flu and COVID infections can awaken dormant cancer cells in mice and humans. Inflammation, IL-6 signaling, and immune cell dynamics were central to the reactivation process. Human ...

Add Yahoo as a preferred source to see more of our stories on Google. Millions of people who recover from infections like COVID-19, influenza and glandular fever are affected by long-lasting symptoms.

Important differences in how the nasal cells of young and elderly people respond to the SARS-CoV-2 virus, could explain why children typically experience milder COVID-19 symptoms, a new study finds.